Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Parechovirus | 2 | 2018 | 48 | 1.40 | Why? |
| Encephalitis, Viral | 2 | 2017 | 355 | 1.00 | Why? |
| Picornaviridae Infections | 2 | 2018 | 544 | 0.95 | Why? |
| Infectious Encephalitis | 1 | 2017 | 20 | 0.72 | Why? |
| Motor Disorders | 1 | 2017 | 45 | 0.69 | Why? |
| Tuberculosis, Meningeal | 1 | 2019 | 100 | 0.68 | Why? |
| Mycoplasma pneumoniae | 1 | 2017 | 233 | 0.61 | Why? |
| Pneumonia, Mycoplasma | 1 | 2017 | 292 | 0.56 | Why? |
| Developmental Disabilities | 1 | 2017 | 257 | 0.53 | Why? |
| Vaccines, DNA | 1 | 2020 | 871 | 0.52 | Why? |
| Respiratory Syncytial Virus, Human | 1 | 2020 | 846 | 0.51 | Why? |
| Antitubercular Agents | 2 | 2019 | 775 | 0.50 | Why? |
| Australia | 9 | 2020 | 6306 | 0.49 | Why? |
| Hospitals, Pediatric | 3 | 2020 | 1792 | 0.48 | Why? |
| Encephalitis | 1 | 2020 | 797 | 0.48 | Why? |
| Child Health | 1 | 2020 | 940 | 0.43 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2019 | 1115 | 0.42 | Why? |
| Influenza, Human | 4 | 2020 | 10779 | 0.42 | Why? |
| Emigrants and Immigrants | 1 | 2019 | 888 | 0.41 | Why? |
| Respiratory Tract Infections | 2 | 2021 | 6817 | 0.39 | Why? |
| Mycobacterium tuberculosis | 1 | 2019 | 1164 | 0.39 | Why? |
| New South Wales | 3 | 2019 | 336 | 0.38 | Why? |
| Brain Diseases | 2 | 2018 | 1463 | 0.38 | Why? |
| Vaccines, Synthetic | 1 | 2020 | 3231 | 0.34 | Why? |
| Infant | 11 | 2020 | 30274 | 0.32 | Why? |
| Child | 18 | 2021 | 70012 | 0.30 | Why? |
| Communicable Diseases | 1 | 2020 | 2148 | 0.29 | Why? |
| Bacterial Infections | 1 | 2018 | 2229 | 0.27 | Why? |
| Infant, Newborn, Diseases | 2 | 2019 | 394 | 0.27 | Why? |
| Communicable Diseases, Emerging | 1 | 2018 | 2523 | 0.26 | Why? |
| Tuberculosis | 1 | 2019 | 2895 | 0.25 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.24 | Why? |
| C-Reactive Protein | 1 | 2018 | 7972 | 0.22 | Why? |
| Infant, Newborn | 6 | 2019 | 23105 | 0.21 | Why? |
| Sentinel Surveillance | 2 | 2017 | 1093 | 0.20 | Why? |
| Heterotaxy Syndrome | 1 | 2019 | 18 | 0.20 | Why? |
| Clothing | 1 | 2020 | 100 | 0.20 | Why? |
| Child, Preschool | 8 | 2020 | 36283 | 0.20 | Why? |
| Viral Vaccines | 1 | 2020 | 7560 | 0.19 | Why? |
| Ibuprofen | 1 | 2020 | 156 | 0.18 | Why? |
| Civil Rights | 1 | 2020 | 113 | 0.18 | Why? |
| Neopterin | 1 | 2018 | 69 | 0.18 | Why? |
| Panic | 1 | 2020 | 161 | 0.18 | Why? |
| Tuberculin Test | 1 | 2018 | 141 | 0.18 | Why? |
| Bronchitis | 1 | 2019 | 146 | 0.17 | Why? |
| Epidemics | 1 | 2018 | 6407 | 0.17 | Why? |
| Neonatal Sepsis | 1 | 2018 | 69 | 0.17 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.16 | Why? |
| Interferon-gamma Release Tests | 1 | 2018 | 253 | 0.16 | Why? |
| Pneumonia, Viral | 10 | 2020 | 243684 | 0.16 | Why? |
| Syndrome | 1 | 2021 | 1310 | 0.15 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.15 | Why? |
| Communicable Disease Control | 3 | 2020 | 29620 | 0.15 | Why? |
| Mycobacterium Infections, Nontuberculous | 1 | 2018 | 167 | 0.15 | Why? |
| Drug Substitution | 1 | 2019 | 385 | 0.15 | Why? |
| Meningoencephalitis | 1 | 2018 | 208 | 0.15 | Why? |
| Latent Tuberculosis | 1 | 2018 | 324 | 0.14 | Why? |
| Analysis of Variance | 1 | 2017 | 950 | 0.13 | Why? |
| Pandemics | 11 | 2021 | 389249 | 0.13 | Why? |
| Humans | 29 | 2021 | 930598 | 0.13 | Why? |
| Disease Transmission, Infectious | 4 | 2020 | 9044 | 0.12 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.11 | Why? |
| Tuberculosis, Multidrug-Resistant | 1 | 2017 | 433 | 0.11 | Why? |
| Drug Approval | 1 | 2021 | 1325 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.10 | Why? |
| Lymphohistiocytosis, Hemophagocytic | 1 | 2019 | 800 | 0.10 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 1454 | 0.10 | Why? |
| History, 21st Century | 1 | 2017 | 1849 | 0.10 | Why? |
| Adolescent | 6 | 2021 | 86841 | 0.10 | Why? |
| Immunization | 1 | 2019 | 2019 | 0.10 | Why? |
| Seizures | 1 | 2018 | 1163 | 0.09 | Why? |
| Prospective Studies | 3 | 2020 | 43301 | 0.09 | Why? |
| Refugees | 1 | 2018 | 809 | 0.09 | Why? |
| Tuberculosis, Pulmonary | 1 | 2019 | 1171 | 0.09 | Why? |
| Carrier State | 1 | 2020 | 2100 | 0.09 | Why? |
| Cystic Fibrosis | 1 | 2018 | 1104 | 0.09 | Why? |
| Schools | 2 | 2021 | 4187 | 0.09 | Why? |
| Shock, Septic | 1 | 2018 | 1313 | 0.09 | Why? |
| Electronic Health Records | 1 | 2020 | 3492 | 0.08 | Why? |
| Ambulatory Care Facilities | 1 | 2018 | 2063 | 0.08 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.08 | Why? |
| Female | 10 | 2020 | 380317 | 0.07 | Why? |
| Seasons | 1 | 2017 | 4071 | 0.07 | Why? |
| Biomarkers | 2 | 2018 | 23361 | 0.07 | Why? |
| Magnetic Resonance Imaging | 2 | 2018 | 6551 | 0.07 | Why? |
| Public Health | 2 | 2020 | 16359 | 0.07 | Why? |
| Public Health Surveillance | 1 | 2017 | 3129 | 0.07 | Why? |
| Health Status | 1 | 2017 | 3259 | 0.07 | Why? |
| Male | 10 | 2020 | 367725 | 0.07 | Why? |
| Sepsis | 1 | 2018 | 3517 | 0.05 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.05 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.05 | Why? |
| Incidence | 2 | 2019 | 25622 | 0.05 | Why? |
| Brain | 1 | 2017 | 5133 | 0.05 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.05 | Why? |
| Health Personnel | 2 | 2020 | 29646 | 0.05 | Why? |
| Global Health | 2 | 2020 | 13911 | 0.05 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.05 | Why? |
| Mycobacterium abscessus | 1 | 2018 | 31 | 0.05 | Why? |
| Prevalence | 2 | 2018 | 25773 | 0.05 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.04 | Why? |
| Masks | 1 | 2020 | 8528 | 0.04 | Why? |
| Nontuberculous Mycobacteria | 1 | 2018 | 114 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.04 | Why? |
| Treatment Outcome | 2 | 2019 | 51732 | 0.04 | Why? |
| Rare Diseases | 1 | 2019 | 373 | 0.04 | Why? |
| Cohort Studies | 1 | 2017 | 36005 | 0.03 | Why? |
| New Zealand | 1 | 2020 | 2073 | 0.03 | Why? |
| Lung Transplantation | 1 | 2018 | 1554 | 0.02 | Why? |
| Decision Making | 1 | 2020 | 3132 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2019 | 7220 | 0.02 | Why? |
| Mass Screening | 1 | 2018 | 8005 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.01 | Why? |
| Retrospective Studies | 2 | 2018 | 105322 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.01 | Why? |
Britton's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(117)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(49)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_